Study of Personalized Cancer Therapy to Determine Response and Toxicity
Recruiting now
Conditions studied: Cancer
In brief
The purpose of this study is to learn more about personalized cancer therapy including response to treatment and side effects. Information about the tests and treatments a person received, or will receive, for their cancer will be collected from medical records to help the researchers determine whether or not patients respond better when their physicians choose to treat them according to the genetic makeup of their tumor. Optional research tests may be performed on tissue, body cavity fluid, blood or urine provided, discarded biological samples taken during routine care that would normally be disposed of and not saved, or on blood samples collected for this study. These research tests will be used to create a "profile" of the collected specimens which will describe unique characteristics about the genes involved in a person's cancer. The tests will also help researchers look for biomarkers that may help predict how people respond to treatment.
Key facts
- Study ID
- NCT02478931
- Run by
- Shu Mei Kato
- People needed
- 10000
- Starts
- 2013-09-05
- Expected to finish
- 2027-09-05
- Last updated by the study team
- 2026-03-31
Who can join
Age: 7 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Must be willing to provide informed consent, parent permission, or assent
You may not qualify if…
- Subjects unable to give informed consent, parent permission, or assent
Where it is running
- UCSD Moores Cancer Center — La Jolla, California, United States (enrolling)
- Eisenhower Medical Center, Lucy Curci Cancer Center — Rancho Mirage, California, United States (enrolling)
- Rady Children's Hospital, San Diego — San Diego, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.